Quest PharmaTech (TSXV:QPT) Short-Term Debt : C$1.00 Mil (As of Oct. 2023)

View and export this data going back to 1999. Start your Free Trial

What is Quest PharmaTech Short-Term Debt?

Quest PharmaTech's Short-Term Debt for the quarter that ended in Oct. 2023 was C$1.00 Mil.

Quest PharmaTech's quarterly Short-Term Debt increased from Apr. 2023 (C$0.80 Mil) to Jul. 2023 (C$1.00 Mil) but then stayed the same from Jul. 2023 (C$1.00 Mil) to Oct. 2023 (C$1.00 Mil).

Quest PharmaTech's annual Short-Term Debt increased from Jan. 2021 (C$0.25 Mil) to Jan. 2022 (C$0.50 Mil) and increased from Jan. 2022 (C$0.50 Mil) to Jan. 2023 (C$1.00 Mil).

Quest PharmaTech Short-Term Debt Historical Data

The historical data trend for Quest PharmaTech's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest PharmaTech Short-Term Debt Chart

Quest PharmaTech Annual Data

Trend

Jan14

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Short-Term Debt

Get a 7-Day Free Trial

2.65

0.25

0.50

1.00

Quest PharmaTech Quarterly Data
	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23
Short-Term Debt	Get a 7-Day Free Trial															1.00	1.00	0.80	1.00	1.00

Quest PharmaTech Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Quest PharmaTech Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Quest PharmaTech's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Quest PharmaTech (TSXV:QPT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quest PharmaTech Inc (TSXV:QPT) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

8123 Roper Road NW, Edmonton, AB, CAN, T6E 6S4

Website

http://www.questpharmatech.com

Quest PharmaTech Inc is a Canadian-based pharmaceutical company developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at the University of Nebraska Medical Center. The company is also developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications.

Executives

Ragupathy Madiyalakan

Director

Quest PharmaTech (TSXV:QPT) Headlines

No Headlines